Hunan Runxing Pharmaceutical Co., Ltd.

Hunan Runxing Pharmaceutical Co., Ltd. was established on August 8, 2019, located in *Economic and Technological Development Zone---North Park of Liuyang Economic and Technological Development Zone, Hunan, covering an area of nearly 100,000 square meters. It is a modern, high-end pharmaceutical scale enterprise dedicated to high-end cardiovascular and anti-tumor new drug formulations and active pharmaceutical ingredients, integrating R&D, production, and sales.
The total project investment is approximately 505 million yuan, with a designed construction area of approximately 70,000 square meters. The main construction is expected to start in the first half of 2020, and the plant is expected to be completed in the second half of 2021, entering the equipment installation and commissioning stage. The plant design meets the *high requirements of GMP/FDA regulations, and the construction will meet the *high standards of national safety supervision, environmental protection, and pollution discharge. The equipment meets the high standards of an intelligent, large-scale, and modern pharmaceutical factory in the industry. Mainly new large functional buildings such as office buildings, R&D buildings, quality control centers, finished product warehouses, workshops, and tank farms will be built. After the company's plant is completed, it will become a first-class large-scale, modern pharmaceutical R&D and production base in China.
The company is driven by faith, belief, and confidence to contribute to the cause of human health, and driven by talent for the future, striving to become a *new type of high-tech API enterprise.